The largest database of trusted experimental protocols

Factor b

Manufactured by Merck Group

Factor B is a laboratory reagent used in the analysis of biological samples. It is a protein involved in the complement system, which is a part of the immune response. Factor B plays a role in the activation of the alternative pathway of the complement system. This product is intended for research use only and its specific applications should be determined by the user.

Automatically generated - may contain errors

2 protocols using factor b

1

Quantifying C3 Convertase Regulation by FHR1

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the potential effect of FHR1 on the FH-mediated regulation of the C3bBb, C3 convertase assay was performed as previously described (24 (link)). In brief, at first 5μg/ml C3b (Complement Tech) were immobilized in the microtiter plates. After blocking with 3% milk in 0.02%TBST for 2 hours at 25°C, 4μg/ml factor B (Millipore), 8μg/ml properdin (Millipore), 0.2μg/ml factor D (Millipore), 20μg/ml BSA (Sigma-Aldrich), altogether with 100nM factor H (Complement Tech) and serially diluted FHR1*A or FHR1*B (300nM-500nM) were added. After incubation, anti-factor B goat polyclonal antibody (Sigma-Aldrich) was added for incubation, followed by adding AP-conjugated rabbit anti-goat IgG antibody (Sigma-Aldrich). Finally, after incubated with alkaline phosphatase chromogenic substrate, the optical density was read at 405 nm.
+ Open protocol
+ Expand
2

Complement System Serum Depletion Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal human serum (Serum), as well as the complement series depleted serum (Serum-C1, C2, C3, C5, C6) were obtained from Sigma. Rabbit serum was also obtained from Sigma. Antibody-depleted serum (Serum-Ig), with the control serum were from SCIPAC. Serum depleted of C4 (Serum-C4), factor B (Serum-fB) and factor D (Serum-fD), along with matching control serum was from Quidel. Mouse and cat serum were from Equitech Bio Inc. Heat inactivation was carried out at 52°C for 45 minutes. EGTA treatment was by adding 0.2M EGTA in 0.2M MgCl2. Purified complement C3, factor B and factor D were from Millipore. Cobra venom factor (CVF) was purified from Naja naja kaouthia venom (MP Biomedicals) using the method of Vogel and Muller-Eberhard(55 (link)). Recombinant human rhinovirus 3C protease was from Expedeon Enzymes, and recombinant poliovirus 3C protease prepared by I. Goodfellow, University of Cambridge. Serum was used at the maximum concentration which had no impact on entry, as found by the endosomal disruption assay (typically 1/5 to 1/10 dilutions in PBS); with depleted serum verified using sheep red blood cell hemolysis assays(56 ).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!